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Abstract Intrinsically disordered proteins (IDPs) do not,
by themselves, fold into a compact globular structure. They
are extremely dynamic and flexible, and are typically
involved in signalling and transduction of information
through binding to other macromolecules. The reason for
their existence may lie in their malleability, which enables
them to bind several different partners with high speci-
ficity. In addition, their interactions with other
macromolecules can be regulated by a variable amount of
chemically diverse post-translational modifications. Four
kinetically and energetically different types of complexes
between an IDP and another macromolecule are reviewed:
(1) simple two-state binding involving a single binding site,
(2) avidity, (3) allovalency and (4) fuzzy binding; the last
three involving more than one site. Finally, a qualitative
definition of fuzzy binding is suggested, examples are
provided, and its distinction to allovalency and avidity is
highlighted and discussed.
Keywords IDP  Allovalency  Fuzzy complex 
Signalling  Avidity  Disorder  Kinetics
Introduction
Signalling and regulation are essential to all living cells
and are based on intermolecular interactions, most of which
are mediated by proteins. A substantial fraction of proteins
include large regions of disorder without clearly defined
three-dimensional structure. Such intrinsically disordered
proteins (IDPs) are not only very abundant—30–40% of all
proteins in the human proteome are disordered or contain
intrinsically disordered regions (IDRs) [1, 2]—they also
constitute significant parts of membrane proteins [3, 4] and
occupy pivotal positions in cellular regulation on all levels
[5]. Some even display enzymatic activity [6]. Thus, IDPs
are critically involved in key cellular processes and
important for understanding life. Although IDP research
has grown somewhat independent from traditional biology
and biochemistry, it is conceptually important to follow the
models, views and nomenclatures used generally for pro-
teins, which have been developed over the past 120 years
since Fisher proposed the lock-and-key model for ligand
binding [7]. Thus, throughout this review the IDP is
referred to as the ligand (L). The residues involved in
binding are expected to be disordered, but that does not
exclude the presence of ordered regions in other parts of
the peptide chain. In the present discussion, ordered
regions are assumed not to be involved in the interaction.
The binding partner that may or may not be an IDP is
referred to as the receptor (R), although this macro-
molecule does not need to be a receptor per se.
By definition, IDPs have high rotational freedom and
sample a wide range of conformations [8–10]. Their hyper-
dynamical nature renders them malleable and thereby
potentiates their ability to bind multiple structurally diverse
receptors, while retaining specificity. This conjecture
implies that IDPs are superior to their folded counterparts
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when it comes to binding many different partners. Inter-
estingly, the thermodynamics of the interaction between an
IDP and a folded partner is essentially similar to the situ-
ation when two globular proteins interact, only
compromised on average by around 2.5 kcal mol-1 due to
loss of conformational entropy originating from the struc-
turing of the disordered chain [11]. However, the
distribution of states and the dynamics of the complexes
vary. Some IDP binding sites become ordered upon bind-
ing to their receptor, a phenomenon called folding upon
binding [12]. Several crystal and NMR structures of such
complexes exist [13, 14] and they highlight details of the
interactions [15–18]. In terms of kinetics, these are typical
examples of simple two-state reactions, where the energy
landscape of the complex is presented by a very deep well
and one single structure can, in essence, represent the
complex. At the other extreme, some ligands never ‘rest’ in
complex with a receptor and there is no single conforma-
tion for the ‘bound-state’. In this case, the IDP ligand
retains conformational freedom in the complex. Such
interactions have recently been coined fuzzy complexes
[19, 20] and a database has been established, collecting
examples of the phenomenon [21]. Between these
extremes, other binding modes are found. Earlier work has
provided kinetic interpretations of those modes and their
mechanisms of binding have been referred to as avidity and
allovalency [22, 23]. In the following, we will describe the
four different mechanisms in more details.
Simple two-state binding
The simplest description of the interaction between two
molecules is that the molecules in their unbound state are
separated from the complex state by a single transition state
and that no intermediates are present (Fig. 1a). Such a
scenario is often seen for the interaction between small
molecules that exist mainly in one conformation. The
interaction between complex macromolecules can often be
approximated as two-state binding, even if the binding
involves major conformational changes. The requirement
for (approximate) two-state binding is that a single site of
the ligand binds a single site on the receptor. In an ordered
protein complex, that can be the end-result of a two-state
reaction, each back-bone conformation adopts a narrow
range of angular values in the bound state and all ligand
atoms involved in binding are bound to specific receptor
atoms, as crystal structures of such complexes show.
Besides those cooperative events that occur within a single
binding site between individual atoms, the binding energy
is linearly dependent on the sum of interactions.
The binding is a second order reaction and there are no
subsequent first order reactions. An example is the
intrinsically disordered protein PUMA binding to the folded
protein MCL-1 [24]. PUMA adopts an a-helix in the bound
state and the helix forms in a coupled binding and folding
event [24]. For the two-state reaction between a ligand (L)
and its receptor (R) the following equilibrium exists:
Lþ R
kon

koff
LR: ð1Þ
The binding constant given as the association constant,
Ka is defined by the concentrations of the species in the
solution at equilibrium:
Ka ¼ kon
koff
¼ ½LR½L½R : ð2Þ
Avidity
Avidity was originally used to describe the binding
between an antibody and an antigen, and is thus not
exclusively an IDP phenomenon [25]. Avidity arises when
two or more binding sites are present on the ligand, com-
plementing two or more binding sites on the receptor
(Fig. 1b). The binding sites on the ligand are connected by
a linker and this linker ensures that once one site is bound
to the receptor, other site(s) are spatially close to other
receptor sites, resulting in cooperative binding, due prin-
cipally to a lower entropic cost of binding more than one
ligand [26]. Avidity requires the receptor and the ligand to
have the same number of binding sites, where each site is
unique and the sites cannot exchange. Once the ligand has
bound one site, the probability of establishing an additional
binding contact is much higher than for the first binding
event and so forth, introducing cooperativity.
The first binding event is a second order reaction,
whereas subsequent binding events are first order (pseudo-
intramolecular) events. Thus, the entropic loss in subse-
quent binding events is lower.
If both of the two receptor-sites and the two ligand-sites
are identical the order of binding is of no consequence. The
first (second order) reaction is written as a simple two-state
reaction:
Lþ R
L0 þ R0
  k1

k1
LR
L0 þ R0
 
; ð3Þ
and likewise, the second (first order) reaction is written:
LR
L0 þ R0
  k2

k2
LR
L0R0
 
; ð4Þ
where L0 and R0 refer to the sites involved in the second
event. The first binding event can typically be studied
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experimentally using mutant proteins. The second step is
trickier but the equilibrium constant for the second step,
K2, may be estimated from the equilibrium constant for the
first step, K1, by calculating the effective concentration of
the second binding epitope in the vicinity of the receptor
[25]:
K2
K1
¼ V
N
3
2phri3 ; ð5Þ
where V is the volume of a sphere with N receptor binding
sites, i.e. V/N is the concentration of receptor binding sites.
‹r› is the average distance between the two binding sites on
the disordered ligand. If LR and L0R0 are identical, then koff
must be the same for both sites. This infers that the ratio
between the on-rates, k2/k1, will be the same as that given
for the equilibrium constants in Eq (5). Since the linker is
disordered, its properties, in terms of dimensions, rigidity
and modulation of dynamics and flexibility potentially by
post-translational modifications, may influence the avidity
by modulating ‹r› [27, 28]. Once the linker gets too long,
the two sites decouple and the cooperativity is lost [25, 27].
Allovalency
Allovalency is different than avidity and refers to the situa-
tion where more and identical receptor-binding sites (n) are
positioned in tandem on an IDP, Fig. 1c. The concept was
developed by Klein, Pawson and Tyers in 2003 [22] and
discussed and elaborated by others [23, 29]. The identical
binding sites on the ligand compete for a single binding site
on the receptor and only one binding site on the ligand can
bind at any given time [22], which is nicely exemplified by
multiple phosphorylations on an IDP binding to and com-
peting for the same site [30]. Although the affinity for one
ligand is low, the presence and competition by multiple
tandem sites increase the overall affinity. To explain this
increased affinity a sphere centred at the receptor binding site
was defined [22].When a ligand molecule enters this sphere,
e.g. is captured from the bulkwith a rate kcap, it is entering the
proximal region (P) from the free state (F), Fig. 1c. The
ligand can then either escape again by diffusion to the free-
state (LF) beyond the sphere with a rate of kesc, or bind with
one of its binding sites to the receptor (the bound state, RL)
with a rate constant of kon. The reverse of this reaction
happens with the rate constant koff
The values of kesc and kon depend on n, whereas koff and
kcap do not, since at any given time, only one ligand site
can occupy the binding site on the receptor, and entering
the P zone from the F zone is a diffusion process that only
depends on [L]. The rate constant kesc thus decreases
exponentially with n, introducing the cooperativity of the
system.
kescðnÞ  e
ðkon nð Þx
35
Þ
x
; ð7Þ
where x is the mean exit time of L from the proximal
region P to bulk [22].
The defining example of allovalency is Sic1, an IDP
from yeast, and its receptor Cdc4. The interaction depends
on phosphorylation of up to ten serine and threonine resi-
dues on Sic1 [22]. Each of these phosphorylated epitopes
can target a single binding pocket on Cdc4. The binding is
cooperative, as when less than six sites are phosphorylated
there is almost no binding. Phosphorylation of the sixth
arbitrary group produces strong binding and further phos-
phorylation increases the affinity in a non-linear way. The
fraction of bound Sic1 to Cdc4 is thus described as:
½LR
ð LR½  þ L½ Þ ¼
1
1þ 1
Ka½Rf 
; ð8Þ
where [Rf] is the concentration of the free receptor. The
association constant, Ka, becomes,
bFig. 1 Illustration of four different binding mechanisms involving
IDPs. Different ligand-receptor interactions involving an IDP ligand
(wavy black string) and a macromolecular receptor (orange oval) are
shown. The binding epitopes on the ligand are highlighted in blue or
(red), whereas a binding site on the receptor is symbolised with an
indentation. a Simple two-state binding, implying the existence of
either the free or the bound state with no intermediates. There is a
linear correlation between the concentration of ligand and the fraction
of molecules in the bound state. b Avidity, where two or more
epitopes on the ligand and a corresponding number of binding sites on
the receptor will interact. If one interaction is established, a second
binding event is more likely to occur due to the proximity of the
additional interaction site(s). c Allovalency. A single binding site on
the receptor can bind to several, identical epitopes along the ligand.
When a bound ligand is released, the chance of rebinding is higher
than anticipated from the ligand concentration alone, because of the
very high epitope concentration close to the binding site on the
receptor. An illustration of the capture sphere is shown with the
corresponding rate constants. d Fuzzy complex. Both molecules have
a number of interaction sites (shown as white circles on the receptor).
An interaction site on the ligand is not restricted to connect with one
specific interaction site on the receptor and vice versa. Thus, when
one interaction is lost, the probability of forming another one because
of the high local concentration of both ligand and receptor binding
sites is much higher than what one would anticipate from ligand
concentration alone. The smaller representation of the bound states in
c and d is intentional, but not real, and is drawn for clarity only
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Ka ¼ 1þ kon
koff
 
kcap
kesc
: ð9Þ
Allovalent binding where ligand epitopes are created by
post-translational modifications has the potential to
function as a highly cooperative switch. Please note, that
the allovalency model has been discussed and expanded
beyond the present formulation by Locasale [29].
Fuzzy binding
The term fuzzy complex was introduced by Tompa and
Fuxreiter in 2008 [19] and the concept has been further
refined and discussed, both by Fuxreiter and others
[31–33]. The name is inspired by the mathematical term
‘fuzzy logic’ in which the true answer to a question can be
no (0) or yes (1) or any value in between. Thus, analo-
gously in a binding reaction, a ligand can be more than just
fully bound to the receptor or completely free. As a further
extension to this description, fuzzy complexes are ensem-
bles of complexes, which are all needed to be able to fully
describe the bound state (Fig. 1d).
In a wider perspective, all complexes at temperatures
above 0 K are fuzzy. In one extreme, atomic vibrations
cause fuzziness in a solid-state system. The opposite
extreme can be illustrated by non-specific interactions
between atoms or molecules in the gas state. In that light,
treating fuzziness as a distinct biochemical phenomenon
linked to IDPs seems artificial. Fuzzy complexes, however,
challenge the view that a protein–ligand complex occupies
a single structural state, a notion that is fuelled by the
overwhelming amount of crystal structures of protein–li-
gand complexes deposited in the protein data bank.
Obviously, X-ray crystallographic data are biased towards
non-dynamic molecules. A fuzzy complex is dynamic in
the bound state and occupies several conformational states.
Consequently, crystallographic methods are not sufficient
for realistic visualization. If a crystal could be grown with a
fuzzy complex, the electron density at the binding interface
would be the average of all the conformations present in
the crystal and hardly possible to interpret. Alternatively, a
single state is allowed in the crystal lattice, producing a
misleading artefact, at best describing one out of many
possible states. Having said that, it is important to mention
an interesting study employing SAXS, NMR and X-ray
crystallography to investigate the binding of an intrinsi-
cally disordered region of ribosomal S6 kinase1 (Rsk1) to
its inhibitor S100B. The investigators caught different
Rsk1 structures in different crystal forms of the complex
and were able to describe the fuzzy complex using data
obtained by all three techniques [34]. To our knowledge,
the first fuzzy complexes discovered were the
homodimerization of the intracellular region of the T cell
receptor subunit f and, subsequently, the heterodimeriza-
tion of the same receptor region with a folded protein (Nef
protein core from simian immunodeficiency virus) [35].
Although dynamic dimers of IDPs exist [36], the existence
of homo-dimers in the former publication has been chal-
lenged [37] and importantly, so has the initial notion that
fuzzy complexes can form without any peak perturbations
in the NMR spectra [38]. However, the nature of fuzzy
complexes and the degree by which we currently under-
stand them, combined with the degree by which their
formation is manifested in changes in measureable
parameters, challenge the current toolbox of structural
biology. The development of new approaches, in which
single molecules analyses are one important road ahead, is
needed.
Fuxreiter et al. described fuzzy complexes as ‘protein
complexes, where conformational heterogeneity of ID
regions is retained and is required for function’ [32].
However, any bond between two functional groups will
reduce the number of degrees of freedom of the system by
thermodynamic definition. Assuming that conformational
heterogeneity is proportional to the number of microstates
of the system (definitions of conformational heterogeneity
can be found here [39–41]), conformational heterogeneity
cannot be completely retained, not even in a fuzzy com-
plex, because each bound state has lower entropy than each
unbound state.
Although the introduction of fuzziness and fuzzy com-
plexes as concepts has been tremendously important for
driving our understanding of IDPs, a stricter definition of
fuzzy complexes is needed. Thus, to further advance the
field, a formal definition of the fuzzy phenomenon in terms
of molecular dynamics and kinetics is necessary. This
definition must explain the affinity/kinetics and fuel the
design of experiments that can directly test for the fuzzy
phenomenon. Here we describe fuzziness as two or more
ligand binding sites on the receptor being able to bind to
two or more receptor binding sites on the ligand. In a sense
this is a combination of two allovalency phenomena, one
experienced by the ligand and one experienced by the
receptor (Fig. 1d). We only describe this conceptually, and
present no formalistic description, but refer to Vauquelin
et al., who have described the simplest system formalisti-
cally where n = 2 for each partner of the complex [42, 43].
What makes fuzzy binding special?
A fuzzy complex consists of an intrinsically disordered
ligand and a receptor (which may and may not be disor-
dered itself). The complex, once established, does not lead
to a single ligand (and in some cases receptor)
Behaviour of intrinsically disordered proteins in protein–protein complexes with an emphasis… 3179
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conformation, rather the ligand samples a large confor-
mational space as functional groups bind and unbind the
receptor. A functional group could be PO4
2-, NH3
?, O-,
OH, CH3, a ring system etc., i.e. any functional group in a
protein. The ligand-receptor sub-sites recombine during
binding and individual interactions within the interface are
short lived compared to the overall life-time of the com-
plex. Furthermore, these individual interactions may
recombine within the life-time of the complex. So one
functional group on one of the proteins may be free to bind
different functional groups on the other protein.
How is fuzziness different from the other mechanisms
presented in this paper? Of the four modes of interaction
described here, fuzziness is most easily confused with (or
similar to) allovalency. The difference is that allovalency
requires several identical binding sites on the ligand and a
single ligand-binding site on the receptor [22]. In the case
of allovalency, the cooperative dependency on the number
of compatible sub-sites is reflected in kesc, because the
probability that an unbound sub-site will rebind to the
receptor, and thus prevent diffusion beyond the proximal
region increases non-linearly with the number of sub-sites.
However, whereas koff is independent on the number of
ligand sites in the case of allovalency, this will not be the
case for fuzzy binding, if one accepts the definition above.
In a fuzzy complex, both the ligand and the receptor con-
tain several ‘sub-binding sites’ or compatible functional
groups, and several of those groups can make contact
simultaneously. This means that the observed koff is
dependent on the number of compatible functional groups
and their individual koffs.
Although described individually, we anticipate the dis-
covery of hybrid examples, where two or more receptor
binding sites can bind several binding sites on the ligand
and where both koff and kesc contribute to the cooperative
effect. However, to be able to distinguish between the
different mechanisms in a testable frame, we need for-
malistic descriptions. As far as we know, the exact
formalistic definition of fuzzy complex formation in terms
of how koff depends on the number of groups has not yet
been derived.
Why fuzziness?
One might ask how fuzziness differs from other macro-
molecular complex formation processes. The difference
between a fuzzy complex and unspecific contacts between
macromolecules is that a fuzzy complex has a biological
consequence. The affinity may be ‘high’ or ‘low’ but the
important point is that the result of the interaction has
biological outcome. A lower limit for apparent affinity is
not possible to define and there is no reason to believe that
a higher limit exists beyond which ordered structure is
required. Some fuzzy complexes have reported Kd values
in the nM range [34].
What can fuzziness offer biological systems that other
kinds of complexes cannot? Perhaps the most obvious
answer would be binding at low entropic cost, since a high
degree of conformational heterogeneity is retained in the
complex. However, in general, the negative (unfavourable)
entropy change upon binding is more or less the same for
IDPs as for folded proteins [11]. With the rather few pro-
tein complexes that have been classified as fuzzy so far, it
remains to be seen if fuzzy complexes differ in this respect.
Since the cooperativity of fuzziness depends on n, one
could imagine that in extreme cases this could lead to very
strong binding, pushing the affinity into the pM range for
large number of n. Since disorder is maintained in the
complex, accessibility to modifying enzymes is not com-
promised. Thus, even though the affinity of the complex in
its unmodified form is high, the lifetime of an individual
conformational state is low, which allows for regulation on
the fly. In this context, we notice that fuzzy complexes offer
a scaffold for ideal rheostats [44], in which applying or
removing post-translational modifications at the binding
interface, can tune binding affinity.
In line with the notion that classical interactions
between ordered macromolecules and interactions with
IDPs in fuzzy complexes represent the extremes of a
dynamics trajectory, fuzzy complexes may not require a
fundamentally different explanation [38]. In the following,
we provide two examples, which according to the defini-
tion highlighted above can be classified as fuzzy
complexes.
The complex between nucleoporin and nuclear
transporter receptors
A protein that needs to enter the nucleus can do so by
binding to a soluble protein called a nuclear transport
receptor (NTR). In the nuclear pore these can bind to IDPs
(or disordered regions in globular proteins) called FG-Nups
(phenylalanine-glycine-rich nuclear pore proteins). The
interaction between NTRs and FG-Nups were examined
in vitro by single molecule FRET, NMR and molecular
dynamics simulations [45, 46]. These studies showed that
the IDP only undergoes subtle structural and dynamical
changes in the complex. Each local interaction—the
encounter between complementary functional groups—has
low (mM) affinity but the apparent Kd is around 100 nM
and kon is remarkably high, approaching the theoretical
diffusion limit (*109 M-1 s-1). This hints that the inter-
action may not depend on the relative orientation of the
molecules. The authors suggest that these unique kinetic
characteristics make it possible to ‘grab’ the NTR proteins
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with high affinity, still unbind them efficiently and send
them along to other Nups in the nuclear pore complex, until
they have been transported through the pore with their
passenger protein [45, 46]. Thus, these characteristics fulfil
the expectations of a fuzzy complex.
Clathrin heavy chain binding by AP180
The process of endocytosis involves dynamic interactions
among molecules associated with the membrane. Molecu-
lar rearrangements result in invagination of the membrane
and ultimately in a vesicle budding off. Central to this
process is the association of protein AP180 with the
N-terminal domain of clathrin heavy chain (TD). AP180
contains 12 degenerate motifs in the C-terminal 58 kD
intrinsically disordered region, and each of these *23
residues regions contain a DLL/DLF binding motif. Each
TD domain has three AP180 receptor sites. Aspects of
complex formation has been examined using NMR spec-
troscopy, analytical ultracentrifugation, isothermal titration
calorimetry and X-ray crystallography [47–49]. NMR
spectroscopy studies showed that the TD-bound and free
state of an AP180 fragment containing two TD binding
motifs retained disorder, but the spectra revealed chemical
shift changes. The Kd values of the individual sites were
determined to be around 200 lM. Interestingly, the koff
values were around 3000 s-1 and the kon values were
1–2 9 107 M-1 s-1, approaching those determined for the
NTR—FG-Nup interactions described in the example
above.
The two examples share very high kon and koff values.
This may not be seen as a prerequisite for fuzzy complexes.
A fuzzy complex can in principle exist in slow motion. In
the case of allovalency, however, kon must be higher than
kesc. In spite of the resemblance between the two mecha-
nisms, there are no constraints on kon or koff in fuzzy
binding, except of course that kon/koff[ 1.
Conclusion
Intrinsically disordered proteins form complexes with other
proteins, and may do so by different binding mechanisms.
Allovalency and avidity have been described formalisti-
cally in the literature whereas the phenomenon of fuzzy
complexes has not. It has been put forward conceptually to
describe a binding phenomenon associated with IDPs. In
the present review, we argued that complete conforma-
tional heterogeneity cannot be retained in fuzzy complexes
and that the cooperative dependence on the number of
groups that can participate in binding (n) arises because
both kcap and koff depend on the magnitude of n. Thus, an
important conclusion is that IDP complexes with only one
receptor-binding site are not strictly fuzzy, but must be
described according to the formalisms of allovalency.
Notably, both allovalency and fuzzy complexes are
dependent on the ligand being an IDP, whereas two-state
binding and avidity are not. To this end, the rationale for
the existence of fuzzy complexes is discussed. Fuzzy
complexes can have very low Kd values (nM or lower), but
are not restricted to this, and the binding affinity has the
potential to be rapidly regulated, for example by post-
translational modifications, even when bound. This pro-
vides a versatility and swiftness in signal changes, and
offers the possibility of rheostat regulation, which may not
be possible in the interaction between folded proteins.
Although we did not derive a formalistic description of
fuzzy binding, we strongly encourage its derivation, which
will allow for testable experiments to investigate fuzzy
complex formation to the full.
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Glossary
Allovalency A single receptor site binding to a ligand
with several identical binding epitopes.
Avidity Two or more receptor sites that bind to
two or more ligand epitopes in a
cooperative manner.
Fuzzy complex An IDP (or IDR) binding to a receptor,
constantly shifting the coupling of
functional compatible groups, thereby
retaining some of the conformational
heterogeneity of the free molecule.
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